P atients with f8-thalassemia major present with severe anemia and need continuous transfusion therapy. The consequent iron overload, also caused by extravasal hemolysis and increased iron absorption, leads to hemochromatosis.' Cardiac disorders related to biventricular failure are the most frequent cause of death in this syndrome.2 A few studies have documented initial cardiac dysfunction even in thalassemics without clinical manifestations of heart failure,3,4 also by means of conventional echocardiographic-Doppler techniques.5-7 However, the qualitatively assessed echocardiographic reflectivity of the myocardium remains unchanged in the early phase of the iron-overload disease and becomes clearly abnormal (with increased echogenicity of myocardial walls) only in a few thalassemic patients in the advanced stages of the disease (usually represented by dilated cardiomyopathy).8
Nonconventional quantitative ultrasound methods for tissue characterization have recently proved to be reliable in identifying progressive degrees of histopathological impairment of cardiovascular structures, also in humans.9 '10 In particular, a significant correlation has been found in in vitro1l-'s and in vivo models16"17 between radiofrequency backscattered ultrasound signal increase and the fibrotic and/or calcium content of the target. Moreover, abnormalities in both absolute and cyclic systolic-to-diastolic variations of the quantitatively evaluated radiofrequency reflections of myocardial walls are present in patients with cardiac diseases associated with histomorphological tissue abnormalities, such as cardiomyopathies. [17] [18] [19] The purpose of this study is to assess whether abnormal myocardial wall reflectivity is present in patients with 83-thalassemia major who are receiving transfusion treatment but are free from symptoms due to cardiac dysfunction by means of a simple ultrasound system for on-line quantitative evaluation of the radiofrequency backscattered signal.
Methods

Patient Population
Forty-two patients with 83-thalassemia major (homozygous form) and no clinical signs of cardiac dysfunction were initially considered for the study. After conventional echocardiographic examination, four patients were excluded for instrumental signs of left ventricular dysfunction (end-diastolic diameter .56 mm and/or fractional shortening <30%). The remaining 38 patients were enrolled for conventional and quantitative ultrasound myocardial analysis. No patients were excluded because of a poor-quality acoustic window. Their mean age was 18 years (age range, 7-26 years); 21 of them were male (55%). Demographic data of patients are reported in Table 1 .
Each patient was receiving blood transfusions every 2-3 weeks to maintain hemoglobin levels between 10.5 and 13.5 g/dL. They all were also receiving desferroxiamine as chelation therapy (25-50 mg/kg body wt s.c. infused 4-6 days a week to maintain serum ferritin level below 1,300 ng/mL) to prevent as well as to treat the iron toxicity.20 Hematological data of the patients at the time of ultrasound evaluation are summarized in Table 2 .
Control Group
Twenty age-and sex-matched normal subjects were also studied. They had no personal and/or family history of cardiac or hematological disease and had normal clinical, ECG, and echocardiographic findings. Their mean age was 17 years (age range, 6-30 years); 12 of them were male (60%). Demographic data of patients are reported in Table 1 . Each patient and control underwent on the same day a conventional two-dimensional echocardiographic and transmitral Doppler flow evaluation and a quantitative radiofrequency analysis. Two-dimensional Echocardiography M-mode and two-dimensional echocardiographic tracings were obtained in each subject using a HewlettPackard 77020AI phased-array sector scanner (Andover, Mass.) with 3.5-and 2.5-MHz transducers. Twodimensional images were obtained in the parasternal long-and short-axis views and apical two-and fourchamber views. Left ventricular diameters and wall thicknesses were measured from the two-dimensional targeted M-mode echocardiographic tracings according to the criteria of the American Society of Echocardiography.21 Left ventricular percent fractional shortening was calculated as end-diastolic diameter minus endsystolic diameter divided by end-diastolic diameter and multiplied by 100. Left ventricular mass was calculated by the Penn convention method22 and normalized for body surface (left ventricular mass index).
The wall echoreflectivity was visually and qualitatively assessed by two independent observers as either normal or increased. In case of split decisions (which occurred in six cases), a third observer reviewed the study, and his judgment was binding.
The Doppler transmitral flow velocity profile was obtained from the apical four-chamber view. In each subject, four to six consecutive cardiac cycles with the highest diastolic flow velocity as well as the best signalto-noise ratios were chosen for analysis. The The "native" radiofrequency signal was sampled before the processing chain of the two-dimensional instrument. The radiofrequency signal underwent preamplification, bypassing the receiving circuits of the ultrasonic equipment. The analog signal was fed to an amplifier, and the gain sweep of the amplifier (2-60 dB) was accomplished in 30 steps. This allows full use of the input dynamic range of the analog-to-digital converter. Sampling was performed by a flash converter with 8 bits of amplitude resolution at a rate of 40 MHz. The digitized signal from analog-to-digital converter was analyzed in real time by a hardware prototype developed in our electronics laboratory.24 The two-dimensional acquisition gate was visualized on the two-dimensional image so as to ensure its proper positioning ( Figure 1 ).
For analysis of the myocardium, the gate width was kept at 3 ,usec, which corresponds to 2.35 mm (for 64 points), given the velocity of ultrasound in biological tissues of 1.57 mm/nisec. This allowed for sampling of the radiofrequency signal in the mid subendocardial layers of the myocardium, thus excluding epicardial and endocardial specular reflections. The acquisition gate was placed immediately behind the specular echo of the endocardium (left endocardium for the septum) to minimize the transmural variations in backscatter that are due to the position from which the signal is acquired within the wall. For evaluation of the pericardial echo, a 1.5 -,sec gate length was used (which corresponds to 1.2 mm, for 32 points). The acquisition gate was centered on the strongest pericardial reflections, immediately behind the mitral leaflets. The representative value of reflectivity for both myocardial walls and pericardium was calculated as the mean of three measurements.
The hardware analysis involved the measurement of the integrated amplitude of the rectified radiofrequency signal corresponding to the two-dimensional area selected from the echocardiographic image.
More analytically, the two-dimensional integrated backscatter index (2D-IB) was calculated over a tissue area, i.e., corresponding to a (n-m) segment in depth and a (r-l) segment in lateral displacement, as follows:
Yn Ym represents the processing over the depth of the interrogated tissue; S(xe, yj) is the sequence of the digitized backscattered echoes over the selected two-dimensional area and is expressed in millivolts.
The system provides a simultaneous display of conventional information together with tissue characterization parameters (the 2D-IB alphanumeric index and the lateral displacement profile averaged over the selected depth). Alphanumeric 2D-IB data values are transferred on-line to a personal computer (model AT) for statistical analysis.
Ultrasonic Quantitative Data Analysis
Primary 2D-IB values are highly influenced by interpatient differences in chest morphology, heart structure depth, and ultrasonic impedance. Therefore, to quantitatively assess the reflectivity of the interventricular septum and posterior free wall, we used the percent 2D-IB (as related to pericardial interface).
In particular, 2D-IB results for each heart structure, initially displayed in millivolts, were expressed as percent values, assuming the pericardial interface (from which the peak echo intensity was consistently recorded in each patient) to be 100%. In this manner, the individual pericardial signal strength was used to normalize myocardial signals in each patient following this procedure: The primary 2D-IB measurement (in millivolts) of myocardial wall (septum or posterior wall) reflectivity is divided by the primary 2D-IB measurement (in millivolts) of pericardial reflectivity and the result is multiplied by 100 to obtain the percent integrated backscatter index.18,25,26 have a higher left ventricular mass index -probably due to reduced body surface with respect to age-matched controls. The patients show a significantly higher, although normal, value of transmitral Doppler E/A ratio compared with controls, mainly due to an increased early diastolic flow velocity (E wave). The qualitatively assessed echocardiographic reflectivity of myocardial walls was considered increased in 10 thalassemic patients (interventricular septum in three, posterior wall in one, and both in six) and in none of the controls (26% versus 0%,p<0.01). Pericardial interface echocardiographic appearance was qualitatively judged to be in the normal range in each study subject. Quantitative Ultrasonic Backscatter Data 2D-IB primary, normalized, and percent values of myocardial wall in patients and controls are summarized in Table 4 . To evaluate differences on analyzed heart structures depth in the chest wall, data on the distance from the ultrasound transducer of the acquisition gate on septum, posterior wall, and pericardium, in both patients and control groups, are also presented in Table  4 . The analysis of these data demonstrates that heart structures of patients and controls have no significant differences in the depth value.
Percent backscatter values of both ventricular septum and posterior wall in patients with thalassemia major showed highly significant differences compared with control subjects, exhibiting a diffuse increase in quantitatively assessed myocardial reflectivity (Figure 2) .
In both patients and controls, the ventricular septum showed higher reflectivity than the posterior wall. This finding is consistent with the result obtained in other studies where the same analysis system was used and is very likely due to the different distance of the insonated structures from the focal point of the ultrasonic beam as well as to the different attenuation of the signal.
Relation Between Conventional Echocardiographic and Quantitative Backscatter Results
In patients with thalassemia major, the relation between percent 2D-IB values of the myocardial walls and conventional echocardiographic measurements was analyzed. No Hematological data of patients with 13-thalassemia major were compared with septal and posterior wall percent 2D-IB values for correlation. No significant correlation was identified when considering the years of transfusion therapy (r=0.1 compared with septal percent 2D-IB and 0.04 compared with posterior wall percent 2D-IB, p=NS for both), the total number of transfusions (r=0.2 and 0.1, respectively; p=NS), the years of chelation therapy (r=0.1 and 0.1,p=NS), or the mean ferritin value (r=0.1 and 0.1, p=NS) (Figure 3 ).
Discussion
The results of this study clearly demonstrate that in patients with 3-thalassemia major, even without clinical signs of cardiac functional involvement, there are ab- Chelation time (years) FIGURE 3. Scatterplots of relation between ultrasound quantitative data (here considered as percent integrated backscatter of the interventricular septum [2D-IBJ) and hematological data (transfusion therapy duration, total number of transfusions, and chelation therapy duration) of the study patients. No significant correlations were found considering each of these parameters. normalities in myocardial acoustic properties, probably related to histopathological alterations. The increased reflectivity of myocardial walls found in these patients might be technically explained by several Left ventricular hypertrophy might be another cause of abnormal myocardial acoustic characteristics. In previous studies, we have found an increased echoreflectivity in patients with hypertrophic cardiomyopathy19 but not in the physiological myocardial hypertrophy of athletes,27 suggesting that increased echoreflectivity in hypertrophic cardiomyopathy is probably related to fiber disarray as well as to fibrosis and necrosis foci. 28 The myocardial hypertrophy at times present in hemochromatosis is not associated with fiber disarray; therefore, such morphological changes are not likely to be a major determinant of regional echodensity-partly because left ventricular wall thickness was normal in our study population.
Finally, intracellular iron deposition in hemochromatosis might be responsible for the increased reflectivity of myocardial walls since multiple foci of intracellular iron deposition might create discontinuities in acoustic impedance and generate multiple interfaces, eventually increasing the ultrasonic backscatter. Iron deposition most likely occurs in the heart of patients undergoing frequent blood transfusions, such as thalassemics. In the patients of the present study, however, no significant correlation was found between an acoustic quantitative parameter (septal backscatter) and hematological data (years and number of blood transfusions, years of chelation therapy, and mean serum ferritin value). This finding, although seemingly surprising, is in accordance with reports by others720 who did not find a correlation between hematological parameters and myocardial involvement. The mechanism by which iron overload produces tissue damage has not been well established, but it is generally accepted that iron toxicity begins when the iron load exceeds the tissue-or blood-binding capacity and joins a free pool defined as nontransferritin iron. 29 The amount of iron that can be stored in a tissue depends on the capacity of the tissue to generate storage proteins; as we are not able to evaluate the amount of free pool, only a rough correlation can be derived between storage levels and cardiac toxicity. Therefore, myocardial involvement may occur in the absence of excessive cardiac stores, partly because heart cells have a relatively small amount of storage proteins and are very sensitive to free iron-induced oxygen radicals that are directly responsiFurthermore, it is likely that the system used for quantitative ultrasound analysis can detect the increase in echoreflectivity due to abnormal iron deposition in the myocardium but is not able to identify little variations in the entity of these deposits. Moreover, the entity and progression of fibrotic reaction, another important cause of increased echoreflectivity, can be independent (not correlated) to the entity of iron deposition, which may represent the initial trigger of that reaction.
Thus, the increased echoreflectivity detected in the myocardium of thalassemia major patients might be multifactorial in origin and related to fibrosis, iron stores, or both. The relative role of each factor is difficult to establish in our patients, particularly because no histopathological correlation was available.
The only reliable method to obtain such data in a clinical study, such as this one, is by the use of endomyocardial biopsy, whose results would have allowed a direct correlative analysis between ultrasonic and histological findings. However, this invasive procedure carries a definite risk and is not routinely performed in patients with thalassemia major since no significant beneficial effect on the clinical management of these patients can be obtained through the analysis of its results.
Although echocardiographic indexes of regional and global systolic function were normal in our thalassemic patients, an increased E/A ratio versus normals was detected by Doppler echocardiography. This finding is consistent with previous observations by Spirito et al,7 who showed restrictive diastolic abnormalities by transmitral Doppler in these patients-consisting of increased E wave and reduced flow-velocity deceleration time-in an early phase of cardiac involvement, when symptoms of heart failure are absent and systolic function is normal.
Of interest, the qualitatively assessed reflectivity on two-dimensional echocardiograms did not clearly differentiate patients with markedly increased regional backscatter. This is, however, not surprising in view of the basically different nature of the information provided by radiofrequency backscatter compared with the image brightness of standard two-dimensional images. In fact, the electronic processing in commercially available twodimensional imaging systems heavily manipulates the radiofrequency native signal to optimize the display of specular reflectors, such as endocardial borders. The processes of differentiation, thresholding, nonlinear amplification, and overall and regional gain are aimed at generating a clearly defined, pleasant image but certainly disrupt the linear relation between the signal received by the transducer and the signal displayed in the echo monitor.30 A sampling of the backscattered myocardial signal, although much more complex, allows a more accurate characterization of myocardial acoustic properties.
In conclusion, although further studies are needed to confirm our observation, we emphasize that myocardial tissue characterization with a real-time integrated backscatter imaging system is a useful tool for detecting myocardial abnormalities in patients with thalassemia major before clinical signs of cardiac damage and echocardiographic evidence of left ventricular regional ble for cellular damage.
and global dysfunction are detectable.
